Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescein Sodium and YELLOW 560 in Head and Neck Tumor Resection
NCT04351373Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorescein sodium 10% injection in vestibular schwannoma (VS), meningioma, Head And Neck Paraganglioma (HNPGL), schwannoma, sponsored by Mayo Clinic. Started Oct 2021; status: completed.
02
Drugs
fluorescein sodium 10% injection
03
Conditions
vestibular schwannoma (VS)meningiomaHead And Neck Paraganglioma (HNPGL)schwannoma
Beyond the preview
Go deeper on NCT04351373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04351373.